Terms: = Leukemia AND HLF, Q16534, 3131, ENSG00000108924 AND Treatment
24 results:
1. hlf promotes ovarian cancer progression and chemoresistance via regulating Hippo signaling pathway.
Han T; Chen T; Chen L; Li K; Xiang D; Dou L; Li H; Gu Y
Cell Death Dis; 2023 Sep; 14(9):606. PubMed ID: 37709768
[TBL] [Abstract] [Full Text] [Related]
2. TCF3 gene rearrangements in pediatric B-cell acute lymphoblastic leukemia-A single center experience.
Zerkalenkova E; Menchits Y; Borkovskaia A; Sokolova S; Soldatkina O; Mikhailova E; Popov A; Komkov A; Rumiantseva Y; Karachunskii A; Olshanskaya Y
Int J Lab Hematol; 2023 Aug; 45(4):533-540. PubMed ID: 37058324
[TBL] [Abstract] [Full Text] [Related]
3. Immunostimulation with chemotherapy of a ruthenium-arene complex via blockading CD47 signal in chronic myelogenous leukemia cells.
Hu G; Lv M; Guo B; Huang Y; Su Z; Qian Y; Xue X; Liu HK
J Inorg Biochem; 2023 Jun; 243():112195. PubMed ID: 36996696
[TBL] [Abstract] [Full Text] [Related]
4. Resistance Mechanisms in Pediatric B-Cell Acute Lymphoblastic leukemia.
Jędraszek K; Malczewska M; Parysek-Wójcik K; Lejman M
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328487
[TBL] [Abstract] [Full Text] [Related]
5. Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies.
Padella A; Ghelli Luserna Di Rorà A; Marconi G; Ghetti M; Martinelli G; Simonetti G
J Hematol Oncol; 2022 Jan; 15(1):10. PubMed ID: 35065680
[TBL] [Abstract] [Full Text] [Related]
6. hlf regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk.
Li H; Yang P; Wang J; Zhang J; Ma Q; Jiang Y; Wu Y; Han T; Xiang D
J Hematol Oncol; 2022 Jan; 15(1):2. PubMed ID: 34991659
[TBL] [Abstract] [Full Text] [Related]
7. Successful treatment of TCF3-hlf-positive Childhood B-ALL with Chimeric Antigen Receptor T-Cell Therapy.
Wang T; Wan X; Yang F; Shi W; Liu R; Ding L; Tang Y; Luo C; Yang X; Ma Y; Wang X; Liang H; Li B; Lu J; Chen J
Clin Lymphoma Myeloma Leuk; 2021 Jun; 21(6):386-392. PubMed ID: 33640284
[TBL] [Abstract] [Full Text] [Related]
8. Precision medicine in acute lymphoblastic leukemia.
Pui CH
Front Med; 2020 Dec; 14(6):689-700. PubMed ID: 33074527
[TBL] [Abstract] [Full Text] [Related]
9. Oncofetal hlf transactivates c-Jun to promote hepatocellular carcinoma development and sorafenib resistance.
Xiang DM; Sun W; Zhou T; Zhang C; Cheng Z; Li SC; Jiang W; Wang R; Fu G; Cui X; Hou G; Jin GZ; Li H; Hou C; Liu H; Wang H; Ding J
Gut; 2019 Oct; 68(10):1858-1871. PubMed ID: 31118247
[TBL] [Abstract] [Full Text] [Related]
10. Targeting ADP-ribosylation by PARP inhibitors in acute myeloid leukaemia and related disorders.
Faraoni I; Giansanti M; Voso MT; Lo-Coco F; Graziani G
Biochem Pharmacol; 2019 Sep; 167():133-148. PubMed ID: 31028744
[TBL] [Abstract] [Full Text] [Related]
11. Methotrexate upregulates circadian transcriptional factors PAR bZIP to induce apoptosis on rheumatoid arthritis synovial fibroblasts.
Suzuki K; Yoshida K; Ueha T; Kaneshiro K; Nakai A; Hashimoto N; Uchida K; Hashimoto T; Kawasaki Y; Shibanuma N; Nakagawa N; Sakai Y; Hashiramoto A
Arthritis Res Ther; 2018 Mar; 20(1):55. PubMed ID: 29566767
[TBL] [Abstract] [Full Text] [Related]
12. Poly (ADP-ribose) polymerase inhibitors selectively induce cytotoxicity in TCF3-hlf-positive leukemic cells.
Piao J; Takai S; Kamiya T; Inukai T; Sugita K; Ohyashiki K; Delia D; Masutani M; Mizutani S; Takagi M
Cancer Lett; 2017 Feb; 386():131-140. PubMed ID: 27894958
[TBL] [Abstract] [Full Text] [Related]
13. New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemia.
Moorman AV
Haematologica; 2016 Apr; 101(4):407-16. PubMed ID: 27033238
[TBL] [Abstract] [Full Text] [Related]
14. Genomics and drug profiling of fatal TCF3-hlf-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options.
Fischer U; Forster M; Rinaldi A; Risch T; Sungalee S; Warnatz HJ; Bornhauser B; Gombert M; Kratsch C; Stütz AM; Sultan M; Tchinda J; Worth CL; Amstislavskiy V; Badarinarayan N; Baruchel A; Bartram T; Basso G; Canpolat C; Cario G; Cavé H; Dakaj D; Delorenzi M; Dobay MP; Eckert C; Ellinghaus E; Eugster S; Frismantas V; Ginzel S; Haas OA; Heidenreich O; Hemmrich-Stanisak G; Hezaveh K; Höll JI; Hornhardt S; Husemann P; Kachroo P; Kratz CP; Te Kronnie G; Marovca B; Niggli F; McHardy AC; Moorman AV; Panzer-Grümayer R; Petersen BS; Raeder B; Ralser M; Rosenstiel P; Schäfer D; Schrappe M; Schreiber S; Schütte M; Stade B; Thiele R; von der Weid N; Vora A; Zaliova M; Zhang L; Zichner T; Zimmermann M; Lehrach H; Borkhardt A; Bourquin JP; Franke A; Korbel JO; Stanulla M; Yaspo ML
Nat Genet; 2015 Sep; 47(9):1020-1029. PubMed ID: 26214592
[TBL] [Abstract] [Full Text] [Related]
15. [Life-threatening hypercalcemia as the initial presentation of childhood acute lymphoblastic leukemia].
Poirée M; Dupont A; Gondon E; Boyer C; Dupont D
Arch Pediatr; 2015 Jun; 22(6):608-12. PubMed ID: 25896627
[TBL] [Abstract] [Full Text] [Related]
16. MEIS1 regulates an hlf-oxidative stress axis in MLL-fusion gene leukemia.
Roychoudhury J; Clark JP; Gracia-Maldonado G; Unnisa Z; Wunderlich M; Link KA; Dasgupta N; Aronow B; Huang G; Mulloy JC; Kumar AR
Blood; 2015 Apr; 125(16):2544-52. PubMed ID: 25740828
[TBL] [Abstract] [Full Text] [Related]
17. Human lactoferrin activates NF-kappaB through the Toll-like receptor 4 pathway while it interferes with the lipopolysaccharide-stimulated TLR4 signaling.
Ando K; Hasegawa K; Shindo K; Furusawa T; Fujino T; Kikugawa K; Nakano H; Takeuchi O; Akira S; Akiyama T; Gohda J; Inoue J; Hayakawa M
FEBS J; 2010 May; 277(9):2051-66. PubMed ID: 20345905
[TBL] [Abstract] [Full Text] [Related]
18. EVI-1 interacts with histone methyltransferases SUV39H1 and G9a for transcriptional repression and bone marrow immortalization.
Goyama S; Nitta E; Yoshino T; Kako S; Watanabe-Okochi N; Shimabe M; Imai Y; Takahashi K; Kurokawa M
Leukemia; 2010 Jan; 24(1):81-8. PubMed ID: 19776757
[TBL] [Abstract] [Full Text] [Related]
19. Clock gene modulation by TNF-alpha depends on calcium and p38 MAP kinase signaling.
Petrzilka S; Taraborrelli C; Cavadini G; Fontana A; Birchler T
J Biol Rhythms; 2009 Aug; 24(4):283-94. PubMed ID: 19625730
[TBL] [Abstract] [Full Text] [Related]
20. PAR bZIP-bik is a novel transcriptional pathway that mediates oxidative stress-induced apoptosis in fibroblasts.
Ritchie A; Gutierrez O; Fernandez-Luna JL
Cell Death Differ; 2009 Jun; 16(6):838-46. PubMed ID: 19219069
[TBL] [Abstract] [Full Text] [Related]
[Next]
